{
    "nct_id": "NCT05416554",
    "official_title": "Long-term Cognitive, Neuropsychiatric and Functional Outcomes in Adults Who Have Received Chimeric Antigen-Receptor T-Cell (CAR-T) Therapy for Aggressive Lymphoma at Stanford - A Pilot Study",
    "inclusion_criteria": "* >/= 18 years-old\n* Treated with Axicabtagene ciloleucel CAR-T therapy at Stanford Or\n* Treated with standard commercial Axicabtagene ciloleucel CAR-T therapy elsewhere and followed primarily by SHC Blood and Bone Marrow transplant providers\n* >/= 6 months from the date of CAR-T infusion\n* Fluent in English\n* Able to attend and participate in in-person testing (Arm I)\n* Able to participate in remote video testing with adequate workspace, computer and internet capabilities for a reliable telehealth video connection (Arm II)\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Concurrent enrollment in a CAR-T therapeutics research study\n* Unable to be present for the scheduled testing\n* Unable to participate in testing due to severe cognitive or physical limitation\n* Actively receiving chemotherapy\n* Progressive cancer",
    "miscellaneous_criteria": ""
}